Beneficient (NASDAQ:BENF – Get Free Report) Director Peter T. Cangany, Jr. acquired 75,000 shares of the stock in a transaction that occurred on Tuesday, November 19th. The stock was acquired at an average price of $0.93 per share, with a total value of $69,750.00. Following the completion of the transaction, the director now directly owns 300,000 shares of the company’s stock, valued at $279,000. This trade represents a 33.33 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link.
Beneficient Trading Up 8.0 %
BENF stock opened at $0.95 on Friday. The business’s fifty day moving average price is $1.26 and its 200 day moving average price is $2.42. Beneficient has a 12-month low of $0.72 and a 12-month high of $51.14.
Hedge Funds Weigh In On Beneficient
A hedge fund recently bought a new stake in Beneficient stock. State Street Corp bought a new position in shares of Beneficient (NASDAQ:BENF – Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund bought 59,554 shares of the company’s stock, valued at approximately $73,000. State Street Corp owned approximately 1.40% of Beneficient at the end of the most recent reporting period. Institutional investors own 90.57% of the company’s stock.
Beneficient Company Profile
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments.
Further Reading
- Five stocks we like better than Beneficient
- Retail Stocks Investing, Explained
- MarketBeat Week in Review – 11/18 – 11/22
- How to Effectively Use the MarketBeat Ratings Screener
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
- What is the Dogs of the Dow Strategy? Overview and Examples
- Tesla Investors Continue to Profit From the Trump Trade
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.